Facebook
Twitter
LinkedIn
Forward
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
|
Samuel Cykert, MD, and Christina Yongue, MPH, MCHES, describe the long-lasting racial disparities in breast and lung cancer care, and some of the root causes for these inequities. Participants will learn how a community-academic-medical partnership addressed these disparities by designing system-change interventions based on antiracism principles.
|
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.
|
Yuri Fedoriw, MD, provides a general background of cancer pathology and tissue diagnosis. The development of testing methods and their application will be discussed, as will the limitations and challenges of cancer classification.
|
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
|
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
|
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
|
Zev Nakamura, MD will present on key topics related to cognitive issues experienced by patients with cancer.
|
Erin Kent, PhD, MSc, and Loretta Muss, RN, BA, discuss how to recruit the caregiver into the patient’s plan of care and understanding the role and the stresses of being an oncology caregiver.
|
|